Depression in Newly Diagnosed HIV Patients: Prevalence and Associated Factors in Bamenda, Cameroon

Dépression chez les Patients Nouvellement Diagnostiqués Séropositifs : Prévalence et Facteurs Associés à Bamenda, Cameroun

Authors

  • Tiwa Diane 1. Faculty of Health Science, University of Bamenda
  • Kamga Olen Jean-Pierre 2. Mental Health service of Hopital Jamot of Yaoundé
  • Bassong Pierre-Yves 1. Faculty of Health Science, University of Bamenda
  • Gerald Ngo Teke 1. Faculty of Health Science, University of Bamenda
  • Tchouankeu Kounga Fabiola 2. Mental Health service of Hopital Jamot of Yaoundé
  • Tchouleko Kouamasson Boris 1. Faculty of Health Science, University of Bamenda
  • Mbu Eyongetah Tabenyang 4. Bamenda Regional Hospital
  • Pisoh-Tangnyin Christopher 1. Faculty of Health Science, University of Bamenda

DOI:

https://doi.org/10.5281/hra.v3i8.6893

Keywords:

Depression, associated factors, HIV, Bamenda

Abstract

Introduction. HIV continues to be a major global public health issue, having claimed more than 35 million lives so far. HIV is a stressor that places infected persons at risk for psychological distress. Depression is one of the most common psychiatric disorders in PLHIV. In Cameroon, the management of HIV/AIDS does not take into account psychological aspects of patients hence depression is underdiagnosed. The aim of our study was to determine the prevalence of depression and its associated factors among newly diagnosed HIV positive patients at the Bamenda Regional Hospital, Cameroon.  Methodology. A cross sectional study was carried out at the Bamenda Regional Hospital, for a duration of 6 months (January to June 2018). We recruited 265 participants aged 18years and above. Depression was assessed using a nine-item patient health questionnaire (PHQ-9) with a positive screen defined as PHQ-9 ≥10. Data was analysed using the Statistical Package for Social Science version 23 for Windows. Results. The prevalence of depression was 21.1% with the majority (57%) among depressed patients having symptoms corresponding to moderate depression. Significantly associated factors to mental depression were duration of treatment of HIV of less than 1month (OR 2.98 95% CI 1.20-7.37 p = 0.018) and stopping work after been diagnosed HIV positive (OR 9.94 95% CI 1.55-63.55 p = 0.015). Conclusion. There is a high prevalence of depression among newly diagnosed HIV infected patients with associated factors including duration of treatment of HIV less than 1 month and patient stopping work after diagnosis of HIV.

Introduction. Le VIH continue d'être un important problème de santé publique à l’échelle mondiale, ayant causé plus de 35 millions de décès à ce jour. Le VIH constitue un facteur de stress qui expose les personnes infectées à un risque de détresse psychologique. La dépression est l’un des troubles psychiatriques les plus fréquents chez les personnes vivant avec le VIH (PVVIH). Au Cameroun, la prise en charge du VIH/SIDA ne prend pas en compte les aspects psychologiques des patients, ce qui conduit à un sou-diagnostic de la dépression. Le but de notre étude était de déterminer la prévalence de la dépression et ses facteurs associés chez les patients nouvellement diagnostiqués séropositifs au VIH à l’Hôpital Régional de Bamenda, Cameroun. Méthodologie. Une étude transversale a été réalisée à l’Hôpital Régional de Bamenda sur une période de six mois (de janvier à juin 2018). Nous avons recruté 265 participants âgés de 18 ans et plus. La dépression a été évaluée à l’aide du questionnaire de santé du patient à neuf items (PHQ-9), un score ≥10 étant considéré comme un dépistage positif. Les données ont été analysées à l’aide du logiciel Statistical Package for Social Sciences (SPSS), version 23 pour Windows. Résultats. La prévalence de la dépression était de 21,1 %, avec une majorité (57 %) des patients dépressifs présentant des symptômes correspondant à une dépression modérée. Les facteurs significativement associés à la dépression étaient une durée de traitement du VIH inférieure à un mois (OR = 2,98 ; IC 95 % : 1,20–7,37 ; p = 0,018) et l’arrêt du travail après le diagnostic de séropositivité (OR = 9,94 ; IC 95 % : 1,55–63,55 ; p = 0,015). Conclusion. Il existe une forte prévalence de la dépression chez les patients nouvellement diagnostiqués séropositifs au VIH, avec des facteurs associés incluant une durée de traitement inférieure à un mois et l’arrêt du travail après le diagnostic.

References

1. HIV/AIDS [Internet]. World Health Organization. [cited 2018 May 14]. Available from: http://www.who.int/news-room/fact-sheets/detail/hiv-aids

2. 200605-fs_subsaharanafrica_en.pdf [Internet]. [cited 2018 May 14]. Available from: http://data.unaids.org/pub/globalreport/2006/200605-fs_subsaharanafrica_en.pdf

3. AIDSinfo | UNAIDS [Internet]. [cited 2018 May 14]. Available from: http://aidsinfo.unaids.org/

4. World Health Organization. Prevent HIV, test and treat all. WHO 2016 (Internet). Available from: http://apps.who.int/iris/bitstream/10665/251713/1/WHO-HIV-2016.24-eng.Accessed 12 May 2018.

5. Bernard C, Dabis F, Rekeneire D N.Prevalence and factors associated with depression in people living with HIV in sub-Saharan Africa: A systematic review and meta-analysis PLoS ONE 2017 (Internet). Available from: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181960.Accessed 14 May 2018.

6. Fekadu N, Shibeshi W, Engidawork E. Major Depressive Disorder: Pathophysiology and Clinical Management. J Depress Anxiety [Internet]. 2016; 6(1). Available from: https://www.omicsonline.org/open-access/major-depressive-disorder-pathophysiology-and-clinical-management-2167-1044-1000255.php?aid=80829.Accessed 14 May 2018

7. World Health Organization. Depression and other common mental disorders. WHO 2017(Internet). Available from: http://apps.who.int/iris/bitstream/10665/254610/1/WHO-MSD-MER-2017.2-eng. Accessed 02 Nov 2017

8. Metsch LR, Pereyra M, Messinger S, Del Rio C, Strathdee SA, Anderson-Mahoney P, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis. 2008 Aug 15;47(4):577–84.

9. Rabkin JG. HIV and depression: 2008 review and update. Current HIV/AIDS Reports. 2008 Nov;5(4):163–71.

10. Obadeji A, O. Ogunlesi A, O. Adebowale T. Prevalence and Predictors of Depression in People living with HIV/AIDS Attending an Outpatient Clinic in Nigeria. Iran J Psychiatry Behav Sci. 2014;8(1):26–31.

11. Atoh Ngum P, Nde Fon P, Ngu R, Siysi Verla V, Luma H. Depression Among HIV/AIDS Patients on Highly Active Antiretroviral Therapy in the Southwest Regional Hospitals of Cameroon: A Cross-Sectional Study. Neurology and Therapy. 2017 Mar 18;6.

12. S Ramlall. HIV-Associated Neuropsychiatric Disorders.2017 [Internet]. Available from: http://www.awacc.org/2014/ppt2016/S%20Ramlall%20-%20HIV- Associated%20Neuropsychiatric%20Disorders.Accessed 14 May 2018

13. L’akoa RM, Noubiap JJN, Fang Y, Ntone FE, Kuaban C. Prevalence and correlates of depression in HIV-positive patients: a cross-sectional study among newly diagnosed patients in Yaoundé, Cameroon. BMC Psychiatry. 2013 Sep 22; 13:228.

14. Gaynes BN, Pence BW, Atashili J, O’Donnell J, Kats D, Ndumbe PM. Prevalence and Predictors of Major Depression in HIV-Infected Patients on Antiretroviral Therapy in Bamenda, a Semi-Urban Center in Cameroon. PLOS ONE. 2012 Jul 31;7(7):e41699.

15. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984 Oct 12;252(14):1905–7.

16. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for Depression in Medical Settings with the Patient Health Questionnaire (PHQ): A Diagnostic Meta-Analysis. Journal of General Internal Medicine. 2007 Oct 12;22(11):1596–602.

17. Asangbeh SL, Sobngwi JL, Ekali GL, Eyoum C, Msellati P. Predictors of depression among patients on art in a rural health district in North West Cameroon. AIDS Care. 2016;28(2):205–8.

18. Bhatia R, Hartman C, Kallen MA, Graham J, Giordano TP. Persons Newly Diagnosed with HIV Infection are at High Risk for Depression and Poor Linkage to Care: Results from the Steps Study. AIDS Behav. 2011 Aug;15(6):1161–70.

19. Wroe EB, Hedt-Gauthier BL, Franke MF, Nsanzimana S, Turinimana JB, Drobac P. Depression and patterns of self-reported adherence to antiretroviral therapy in Rwanda. Int J STD AIDS. 2015 Mar;26(4):257–61.

20. Klis S, Velding K, Gidron Y, Peterson K. Posttraumatic stress and depression among people living with HIV in the Gambia. AIDS Care. 2011 Apr;23(4):426–34.

21. Lochet P, Peyriere H, Lotthé A, Mauboussin JM, Delmas B, Reynes J. Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz. NCBI 2013 (Internet). Available from: https://www.ncbi.nlm.nih.gov/pubmed/12534961?dopt=Abstract.Accessed 19Jun 2018

22. O’Mahony SM, Myint A-M, Steinbusch H, Leonard BE. Efavirenz Induces Depressive-Like Behaviour, Increased Stress Response and Changes in the Immune Response in Rats. NIM. 2005;12(5):293–8.

23. Kibret GD, Salilih SZ. Prevalence and Associated Factors of Depression among HIV Infected Patients in Debre Markos Town Northwest Ethiopia. Int J Emerg Ment Health Hum Resil (Internet). 1970 ;17(4). Available from: https://www.omicsonline.org/open-access/prevalence-and-associated-factors-of-depression-among-hiv-infected-patients-in-debre-markos-town-northwest-ethiopia-1522-4821-1000297.php?aid=66589. Accessed 01 Nov 2017

24. Mohammed M, Mengistie B, Dessie Y, Godana W. Prevalence of Depression and Associated Factors among HIV Patients Seeking Treatments in ART Clinics at Harar Town, Eastern Ethiopia. Journal of AIDS & Clinical Research. 2015 Jun 19;6(6):1–6.

25. Sayles JN, Wong MD, Kinsler JJ, Martins D, Cunningham WE. The Association of Stigma with Self-Reported Access to Medical Care and Antiretroviral Therapy Adherence in Persons Living with HIV/AIDS. J GEN INTERN MED. 2009 Oct 1;24(10):1101.

26. Riolo SA, Nguyen TA, Greden JF, King CA. Prevalence of Depression by Race/Ethnicity: Findings from the National Health and Nutrition Examination Survey III. Am J Public Health. 2005 Jun;95(6):998–1000.

27. Godana W. Prevalence of Depression and Associated Factors among HIV Patients Seeking Treatments in ART Clinics at Harar Town, Eastern Ethiopia. 2015 Jun 19;6.

28. Kitshoff C, Naidoo SS. The association between depression and adherence to antiretroviral therapy in HIV-positive patients, KwaZulu-Natal, South Africa. South Afr Fam Pract (Internet). 2012 ;54(2). Available from: https://www.ajol.info/index.php/safp/article/view/76200.Accessed 19 Jun 2018.

29. Eshetu DA, Meseret S, Woldeyohannes, Kebede MA, Techane GN, Gizachew KD, et al. Prevalence of Depression and Associated Factors among HIV/ AIDS Patients Attending ART Clinic at Debrebirhan Referral Hospital, North Showa, Amhara Region, Ethiopia. Clin Psychiatry (Internet). 2015 ;1(1). Available from: http://clinical-psychiatry.imedpub.com/abstract/prevalence-of-depression-andrnassociated-factors-among-hivrnaids-patients-attending-art-clinicrnat-debrebirhan-referral-hospitalrnnorth-showa-amhara-regionrnethiopia-7463.html.Accessed 1 Nov 2017

Downloads

Published

07/29/2025

How to Cite

Tiwa Diane, Kamga Olen Jean-Pierre, Bassong Pierre-Yves, Gerald Ngo Teke, Tchouankeu Kounga Fabiola, Tchouleko Kouamasson Boris, … Pisoh-Tangnyin Christopher. (2025). Depression in Newly Diagnosed HIV Patients: Prevalence and Associated Factors in Bamenda, Cameroon: Dépression chez les Patients Nouvellement Diagnostiqués Séropositifs : Prévalence et Facteurs Associés à Bamenda, Cameroun . HEALTH RESEARCH IN AFRICA, 3(8). https://doi.org/10.5281/hra.v3i8.6893

Issue

Section

Research Articles

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.